News

August 14, 2025

New method more accurately assesses movement disorder in children

Study on cerebral palsy in humans and mice could inform new treatments.

News Release

July 14, 2025

WashU Medicine selected for Parkinson’s disease training program

Edmond J. Safra Fellowship to fund training of movement disorder specialist in the Department of Neurology.

Medical Campus & Community, National Leaders

June 28, 2025

Three Siblings, One Fatal Gene: A Family’s Fight Against Early-Onset Alzheimer’s

Source: The Wall Street Journal

May 27, 2025

Sleep aid blocks neurodegeneration in mice

Lemborexant, similar sleep drugs show promise in treating disorders related to tau, such as Alzheimer’s disease.

News Release

May 16, 2025

‘Ancient’ brainstem structure evolved beyond basic motor control

Source: The Transmitter

May 12, 2025

Drug to slow Alzheimer’s well tolerated outside of clinical trial setting

Side effects of lecanemab are manageable, study finds.

News Release

March 31, 2025

Highly accurate blood test diagnoses Alzheimer’s disease, measures extent of dementia

Could help determine which patients are likely to benefit from new Alzheimer’s drugs.

News Release

March 19, 2025

Anti-amyloid drug shows signs of preventing Alzheimer’s dementia

Clinical trial of people destined to develop early-onset Alzheimer’s disease shows eliminating amyloid from brain may prevent symptoms, supports need for confirmatory studies.

News Release

March 7, 2025

$4.5 million supports pathbreaking neuroimmunology research

Grant funds WashU Medicine’s pursuit of new treatments for Alzheimer’s disease.

News Release

March 4, 2025

WashU School of Medicine study examines disparities in genetic testing in Black children

Source: St. Louis Public Radio

February 13, 2025

Study highlights barriers to genetic testing for Black children

WashU Medicine’s pediatric neurology uses findings to improve testing access for kids with suspected genetic disorders.

News Release

February 12, 2025

His genes forecast Alzheimer’s. His brain had other plans.

Source: National Public Radio

February 10, 2025

Patient defies genetic fate to avoid Alzheimer’s

Study offers clues to treatment, prevention.

News Release

February 4, 2025

New study will try to stop Alzheimer’s decades before it begins, using experimental Eli Lilly drug

Source: Endpoints News

February 4, 2025

International Alzheimer’s prevention trial in young adults begins

WashU Medicine-led trial evaluating investigational drug from Eli Lilly and Company aims to stop disease before symptoms arise.

News Release

January 17, 2025

Brains of people with sickle cell disease appear older

Study also finds socioeconomic status linked to brain health in adults.

News Release

December 17, 2024

NIH grant funds study of cerebral small vessel disease

Research will look for early warning signs, potential treatment of second-leading cause of dementia.

News Release

August 23, 2024

Multiple sclerosis appears to protect against Alzheimer’s disease

Findings could point to new strategies to treat Alzheimer’s.

News Release

July 30, 2024

Accuracy of diagnostic blood tests for Alzheimer’s disease varies

Head-to-head comparison of 6 tests reveals which ones could replace spinal taps, brain scans.

News Release

July 17, 2024

Psilocybin generates psychedelic experience by disrupting brain network

Study advances efforts to harness drug's mind-altering power to treat mental illness.

News Release

July 11, 2024

Disparidades raciales en la demencia estan determinadas por factores sociales

Un estudio confirma que las diferencias raciales en la función cognitiva no se deben a diferencias en el origen genético.

News Release

July 11, 2024

Racial disparities in dementia determined by social factors

Study indicates racial differences in cognitive function not due to genetic ancestry.

News Release